Trade RZLT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Rezolute, Inc. Common Stock (NV) (RZLT) is trading at US$3.84, down 2.78% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$490.13M. Over the past 52 weeks, RZLT has traded between US$1.07 and US$11.46. On Syfe you can trade RZLT with $0 commission and add it to your watchlist.
| Previous close | US$3.95 |
|---|---|
| Market cap | US$490.13M |
| 52-week range | US$1.07 – US$11.46 |
| Volume | 2.52M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Rezolute, Inc. Common Stock (NV)
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.
Year: 2011
Wedbush Adjusts Price Target on Rezolute to $6 From $5, Maintains Outperform Rating
Jun 3, 11:00 AM · MT Newswires
Rezolute, Inc. Common Stock (NV) (RZLT) stock is trading at US$3.84, -2.78% from the previous close of US$3.95.
The market cap for Rezolute, Inc. Common Stock (NV) (RZLT) stock is approximately US$490.13M.
The 52-week high for Rezolute, Inc. Common Stock (NV) (RZLT) stock is US$11.46.
The 52-week low for Rezolute, Inc. Common Stock (NV) (RZLT) stock is US$1.07.
Rezolute, Inc. Common Stock (NV) (RZLT) does not currently pay a dividend.
Stay on top of RZLT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
